首页> 外国专利> PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, KIT AND METHOD FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS

PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, KIT AND METHOD FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS

机译:用于治疗和/或预防子宫肌瘤和/或子宫内膜异位的药物联合会,白藜芦醇和孕激素的使用,用于治疗和/或预防子宫肌瘤和/或子宫内膜异位的药物组合物,用于治疗和/或预防和治疗子宫肌瘤的药物用于治疗和/或预防子宫肌瘤和/或子宫内膜异位症

摘要

The present invention relates to an association of resveratrol with progestogens, and to pharmaceutical compositions and medicaments containing same, useful for the treatment and/or prevention of myoma and/or endometriosis, reducing the dimensions thereof and controlling the associated symptoms. This association can additionally contain an estrogen component. Also disclosed are a method for treatment and a kit.
机译:本发明涉及白藜芦醇与孕激素的结合,并且涉及用于治疗和/或预防肌瘤和/或子宫内膜异位,减小其尺寸并控制相关症状的药物组合物和包含其的药物。该缔合可以另外包含雌激素成分。还公开了一种治疗方法和试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号